Skip to content

Cumulative live birth after fresh versus frozen single embryo transfer in Chinese women of advanced age undergoing IVF (in-vitro fertilization) /ICSI (Intracytoplasmic sperm injection)

Cumulative live birth after fresh versus frozen single embryo transfer in Chinese women of advanced age undergoing IVF (in-vitro fertilization) /ICSI (Intracytoplasmic sperm injection)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029330
Enrollment
Unknown
Registered
2020-01-25
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertile women of advanced age

Interventions

Group 2:Frozen embryo transfer

Sponsors

Shanghai First Maternity and Infant Hospital Tongji University School of Medicine Shanghai
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 44 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 35-44 years; 2. Women who have normal ovarian reserve (AFC > 6 follicles, or AMH >= 1.2 ng/ml); 3. Infertile couples scheduled for their first IVF/ICSI cycle; 4. Women who will receive either gonadotrophin-releasing hormone agonist protocol or gonadotrophin-releasing hormone antagonist protocol as their COH treatment.

Exclusion criteria

Exclusion criteria: 1. Women with congenital or secondary uterine abnormalities, such as uterine malformations including single-horned uterus, septate uterus or double uterus, adenomyosis, uterine submucosal fibroids, intrauterine adhesions 2. Couples undergoing PGD and PGS; 3. Women with hydrosalpinx; 4. Women with recurrent miscarriage; 5. Women with polycystic ovarian syndrome (PCOS); 6. Women with endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney); 7. Women undergoing blastocyst transfer; 8. Natural cycles or IVM cycles; 9. Sperm donation or egg donation cycles.

Design outcomes

Primary

MeasureTime frame
live birth rate of the trial IVF /ICSI cycle within 12 months after randomisation;

Secondary

MeasureTime frame
clinical pregnancy rate;ongoing pregnancy rate;miscarriages;ectopic pregnancy;ovarian hyperstimulation syndrome;

Countries

China

Contacts

Public ContactMiaoxin Chen

Shanghai First Maternity and Infant Hospital Tongji University School of Medicine Shanghai

chenmiaoxin@51mch.com+86 021-20261000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026